Axon Dx is an independent life sciences technology company focused on the development of advanced fluorescence imaging systems for rare-cell detection.
Our engineering team designed the nCyte™ platform to integrate optical performance, automated scanning, and artificial intelligence driven analytics into a unified system architecture capable of supporting complex cellular analysis workflows.
Axon Dx continues to advance its technology through ongoing research, prototype development and collaboration with scientific and medical partners. We are committed to developing tools that make cancer detection more accessible, more efficient, and more aligned with the realities of patient care.
President & ceo
Kent Murphy, PhD
Dr. Murphy is a recognized national leader in transitioning science into products. For the past 32 years, he has led research and development programs, product development efforts and successfully launched dozens of products that are used around the world in a variety of market applications. Kent has experience and proven success in leading and managing technology teams through research and development all the way through product launch and customer support. Dr. Murphy has built-up and sold numerous companies and created more than 400 jobs in rural, Southwestern Virginia.
Chief Technology Officer
Phil Couch, PhD
Dr. Couch received a Ph.D. in Electro-Optics from Cambridge University in 1989 and is a fellow of the Institute of Engineering Technology. He is an accomplished engineer and co-founder of several successful engineering companies, and brings AXON Dx over 30 years of experience in technology development. Dr. Couch’s expertise lies in a broad background of electronics development and related optical and mechanical design, and in the development of precision instrumentation for many purposes used in the defense, government, energy (oil & gas and electrical power), and medical sectors. Among many products he developed the first fiber optic Ethernet, which was widely deployed in critical infrastructure. Phil brings this wealth of experience to the healthcare field with AXON Dx™ and to the development of the nCYTE™ system.